Investigational Compound Dapagliflozin Added to Metformin Sustained Reductions in Blood Sugar Levels in Adult Patients with Type 2 Diabetes in Two-Year Study Episodes of low blood sugar were less ...

SAN DIEGO--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced results from two 24-week Phase 3 clinical studies examining the investigational ...

Two pharmaceutical companies recently issued voluntary recalls for extended-release versions of the diabetes drug metformin, because it may contain high levels of a cancer-causing chemical, according ...

The concept was simple: If two compounds each individually show promise in preventing colon cancer, surely it’s worth trying the two together to see if even greater impact is possible. In this ...

Two pharmaceutical companies issued voluntary recalls Monday for metformin, an anti-diabetes drug, due to high levels of a cancer-causing compound, according to a release from the U.S. Food and Drug ...

Ozempic, or semaglutide, is a new obesity drug, delivered in the form of a hormone injection. Metformin is a pill that was first developed for type 2 diabetes. Both drugs can help people lose weight, ...

Diabetes, a chronic condition impacting millions globally, often brings along complications like insulin resistance and fatty liver disease. Managing these challenges requires treatments that not only ...

Episodes of low blood sugar were less frequent in patients treated with dapagliflozin added to metformin than in patients treated with glipizide added to metformin In addition to sustained reductions ...